Arcutis stockholders elect all three Class II directors and ratify Ernst & Young

Arcutis Biotherapeutics, Inc.

Bhaskar Chaudhuri received 39.76M votes for, 3.83M withheld; Howard Welgus 30.92M for, 12.66M withheld; Sue-Jean Lin 39.09M for, 4.49M withheld.
Ratification of Ernst & Young as independent auditor for FY 2022: 47.07M for, 48k against, 14k abstain.
Non-binding advisory vote on executive compensation: 41.01M for, 2.07M against, 502k abstain.
Advisory vote on frequency of say-on-pay: majority (43.40M votes) favored one year.
About 51.4M shares outstanding and entitled to vote; broker non-votes were 3.55M on director and say-on-pay proposals.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.